Panel & Networking event on the Future of Contraception Wed, Sept. 28th 2022! 
Where: Harvard Business School
When: Wednesday September 28th, 4-6pm 
Dama Health – A startup using a genetic test and an automated matching system to develop a personalized contraception recommendation platform for women and clinicians.
Rembrand M. Koning – Assistant Professor, Strategy Unit, Harvard Business School, whose recent work focuses on innovation in women’s health and in particular how Roe v. Wade’s reversal will stifle innovation in fertility and contraception.
Cirqle biomedical – Combining human-centric design and mucus engineering to launch a new era in contraception.
Moderated by FemTechnology Summit – Bringing together femtech startups, researchers, chief clinicians and university students for a 360 degree perspective on innovation in women’s health.
Why Join? What does the Future of Contraception look like? Are you curious about what the recent Roe v. Wade reversal means for the future of the field? Would you like to better understand how the European and US femtech landscape differ? Looking for an overview of the different approaches to contraception being taken (holistic prescriptions, genetic testing, non-hormonal contraception , review platforms and more)? Or would you just like to generally connect with others interested in women’s healthcare science, technology, and innovation?
Please join us (and feel free to share and bring friends) for this fascinating panel on the Future of Contraception as a part of FemTechnology Summit’s University Series 2022.

Leave a Reply

Your email address will not be published.